Associate Professor Sonia Shah is a genomics scientist and cardiovascular researcher who contributes to Amyloidosis Africa as Global Scientific Advisor for Genomics and Precision Medicine, supporting research initiatives that integrate genomics, data science, and population health to advance the understanding of cardiovascular diseases.

She leads the Genomics in Health research group at the Institute for Molecular Bioscience, The University of Queensland, where her work focuses on using large-scale genomic data to address key knowledge gaps in cardiovascular disease and improve prevention and treatment strategies. Her research particularly emphasizes increasing representation of underrepresented populations in genomic research to address disparities in cardiovascular outcomes.

Professor Shah is also the lead investigator of the South Asian Genes and Health in Australia (SAGHA) study, a major initiative aimed at improving representation of South Asian populations in cardiovascular and genomics research. Her work explores the genetic architecture of cardiovascular disease and investigates how genomic data can inform disease risk prediction, drug response, and therapeutic discovery.

Earlier in her career, she served as lead analyst for the International Heart Failure Genetics Consortium (HERMES) and has held research positions at leading institutions including University College London and the Queensland Brain Institute. Her research integrates genomics, bioinformatics, and statistical genetics to better understand complex diseases.

She holds a PhD in Cardiovascular Genetics from University College London, an MSc in Bioinformatics, and a BSc in Biochemistry with Biotechnology from The University of Manchester. Her contributions to cardiovascular genomics and data-driven research have earned multiple recognitions, including the National Heart Foundation Future Leader Fellowship and the Queensland Young Tall Poppy Award.

Through her role with Amyloidosis Africa, Professor Shah supports scientific collaboration and provides expertise on genomics, precision medicine, and population-based research approaches that can help advance the understanding of cardiovascular diseases, including rare and underdiagnosed conditions, in diverse populations.